Core Insights - Obesity has become a significant public health challenge, and there is a growing need for scientific weight loss methods and medication [4][36] - The "China Public Health Weight Loss Cognition and Scientific Medication Blue Book" presents a comprehensive view of public awareness regarding weight loss [5][29] Group 1: Public Perception and Knowledge - A high prevalence of "pseudo-science" knowledge exists, with 72.8% of surveyed women and 46.2% of men desiring to be thinner, which far exceeds the actual overweight rate of 10.58% [6] - 84.34% of respondents recognize obesity as a disease, with higher acknowledgment among those with a BMI ≥ 24 (87.66%) compared to those with a BMI < 24 (72.79%) [8] - There is a general lack of medical consultation awareness, with 84% attributing obesity to "lack of self-control" and only 11% of those trying to lose weight seeking hospital treatment [10] Group 2: Weight Perception and Medical Guidelines - Over 60% of individuals with a normal BMI perceive themselves as "slightly overweight," with 60.91% of normal-weight individuals self-identifying as "slightly overweight" [11] - The clinical pathway for obesity treatment includes screening, assessment, intervention, multidisciplinary collaboration, and long-term management, as outlined in the "Obesity Diagnosis and Treatment Guidelines (2024 Edition)" [14][26] Group 3: Medication Awareness and Misconceptions - Public sentiment towards weight loss medications is mixed, with 21.12% of normal-weight individuals using drugs to achieve weight loss, and 48.71% adjusting dosages without medical advice [19] - A common misconception is that medications can fully replace diet and exercise, with 37.14% believing this to be true, while only 27.12% understand that medications cannot substitute for lifestyle changes [22] Group 4: Long-term Weight Management - Long-term weight management relies on multidisciplinary collaboration, integrating dietary, metabolic, and behavioral interventions, with lifestyle management being crucial throughout the weight loss process [26][35] - The blue book emphasizes that effective weight management requires a personalized approach and professional team support for accurate assessment and ongoing management [30][31]

Group 1 - The public's awareness of diabetes and obesity is insufficient, leading to delayed diagnosis and treatment, which can result in severe complications and a heavy burden on patients and society [6][7][8] - May 11 is "World Obesity Day," marking a significant shift in the recognition and treatment of obesity, from national policies to new drug development and outpatient services [5][6] - Healthy lifestyles and exercise are important for preventing and addressing obesity, but experts indicate that obesity cannot be resolved solely through "eating less and moving more" [6][7] Group 2 - The "Obesity Diagnosis and Treatment Guidelines (2024 Edition)" clarify that the causes of obesity include genetic, lifestyle, disease, medication, environmental, and social factors [4] - The emergence of GLP-1 receptor agonists from companies like Novo Nordisk and Eli Lilly has transformed the treatment landscape for obesity, with new guidelines expected to be finalized by August or September 2025 [5][6] Group 3 - In China, approximately 180 million adults suffer from obesity, with the prevalence continuing to rise, yet public awareness remains low [6][7] - A survey revealed that only 16% of obese patients have used weight-loss medications, and a mere 11% sought medical advice, with many believing obesity is not a medical issue [6][7] Group 4 - Obesity is recognized as an endocrine metabolic disease, and without systematic intervention, the risks associated with the disease will accumulate and worsen over time [7][8] - Patients with obesity often have comorbidities such as diabetes, hypertension, and fatty liver, and early intervention through weight management can alleviate or even reverse these complications [9][10] Group 5 - Specialized weight management clinics are emerging, promoting proactive medical help and early screening for chronic disease risks [11][12] - Individualized treatment plans are essential for obesity management, incorporating medication, surgery, and lifestyle adjustments based on the patient's specific situation [12][10] Group 6 - Digital health platforms are being integrated into obesity management, with companies like JD.com and Tencent collaborating with Novo Nordisk to create a comprehensive digital obesity prevention and management system [13][14] - Novo Nordisk's "Novo Care" digital patient service platform aims to enhance treatment adherence and empower patients in long-term self-management of their conditions [14]